Fiscal Year 2024 Competitive Cooperative Agreement Solicitation - Drug Court Training and Technical Assistance
ID: 354410Type: Posted
Overview

Buyer

Office of National Drug Control Policy (ONDCP)

Award Range

$6M - $6M

Eligible Applicants

Nonprofits Without 501(c)(3) Status

Funding Category

Law, Justice and Legal Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354410

Additional Information

https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=111308
Timeline
    Description

    The Office of National Drug Control Policy (ONDCP) is offering a Fiscal Year 2024 Competitive Cooperative Agreement Solicitation for Drug Court Training and Technical Assistance. This initiative aims to provide training and technical assistance to states, local courts, and government units involved with drug courts, focusing on developing and enhancing alternatives to incarceration for individuals struggling with addiction. The program aligns with the President's priority of improving public safety by addressing various issues such as mental health, vocational training, and substance use through evidence-based rehabilitation programs. The total funding available for this cooperative agreement is $6 million, with a single award anticipated, and applications must be submitted by July 31, 2024. For further inquiries, interested applicants can contact the Grants.gov Customer Support at support@grants.gov or call 1-800-518-4726.

    Point(s) of Contact
    support@grants.gov
    Files
    No associated files provided.
    Similar Opportunities
    Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)." This initiative aims to support Small Business Technology Transfer (STTR) grant applications focused on developing innovative and accessible solutions to improve health outcomes for individuals affected by non-disordered drug use. The program emphasizes the creation of affordable interventions that can be implemented in community-based care systems, targeting vulnerable populations with limited access to traditional healthcare services. Funding amounts of up to $400,000 for Phase I and $3 million for Phase II are available, with applications due by December 3, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose." This funding opportunity aims to support research that evaluates prevention strategies aimed at reducing nonfatal and fatal overdoses, particularly among populations at higher risk due to social determinants of health. The initiative is crucial for addressing the ongoing public health crisis related to drug overdoses and substance use disorders, especially among youth. The estimated total program funding is $4.9 million, with an award ceiling of $700,000 and an expected seven awards to be made. Interested applicants must submit their proposals electronically by December 2, 2024, and can direct inquiries to Candis M. Hunter at ncipcerpo@cdc.gov.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications for diverse preclinical and clinical projects that can expedite the FDA approval process for new treatments, addressing the significant public health need for effective therapies for conditions such as cocaine, methamphetamine, and cannabis use disorders. The program will provide cooperative agreements for projects lasting up to three years, with annual budgets capped at $5 million, and applications are accepted on a rolling basis with specific due dates for scientific merit review established throughout 2023 and 2024. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-202.html.
    Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)" aimed at supporting Small Business Innovation Research (SBIR) proposals. This initiative seeks innovative, accessible, and affordable solutions to address health complications arising from non-disordered drug use, including issues such as hypoxia-related brain injuries from opioid overdoses and cardiovascular problems from stimulant use. The program anticipates a total budget of $2 million for approximately 2-5 awards in Fiscal Year 2025, with applications due by December 2, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Addiction Technology Transfer Centers Cooperative Agreement
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Addiction Technology Transfer Centers Cooperative Agreement" aimed at enhancing the behavioral healthcare and primary healthcare workforce for substance use disorder (SUD) treatment and recovery support services. This initiative seeks to accelerate the adoption of evidence-based practices, improve workforce knowledge and skills, and foster collaborations among diverse stakeholders in the field of substance use and co-occurring health disorders. With an estimated total program funding of $8.6 million and an expected 12 awards, eligible applicants include states, territories, Indian tribes, and nonprofit entities. Interested parties can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further information, with the synopsis expected to be posted on January 30, 2023.
    Disaster Recovery National Dislocated Worker Grants to Address the Opioid Crisis
    Active
    Employment and Training Administration
    The Employment and Training Administration of the U.S. Department of Labor is offering National Dislocated Worker Grants aimed at addressing the opioid crisis through disaster recovery initiatives. Eligible applicants, including states, outlying areas, and Indian tribal governments, are encouraged to submit proposals that detail their funding requests, projected participant numbers, and the activities they plan to implement, focusing on job creation and training related to opioid recovery. This funding opportunity, with an estimated total program funding of $100 million and an award ceiling of $100 million, aims to support community resilience and recovery efforts, with applications due by October 31, 2024. For inquiries, applicants can contact Anu Mathew at DOL-ETA-DWG@dol.gov.
    Drug-Free Communities (DFC) Support Program - Competing Continuation (Year 6)
    Active
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is forecasting the availability of grants under the Drug-Free Communities (DFC) Support Program for Fiscal Year 2025. This program aims to establish and strengthen collaborations among community coalitions to prevent and reduce substance use among youth, specifically targeting individuals aged 18 and younger. Eligible applicants include community-based coalitions that have previously received DFC funding and are either resuming after a lapse or entering a second five-year funding cycle. The total estimated funding for this opportunity is $12.5 million, with individual awards ranging from $0 to $125,000, and approximately 100 awards expected to be made. Interested parties should note that applications must be submitted electronically by March 31, 2025, with an anticipated award date of August 29, 2025. For further inquiries, applicants can contact Brandis Belser at dfcnofo@cdc.gov.
    Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity to establish a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through a cooperative agreement. This initiative aims to provide technical development support for researchers working on new digital therapeutics for SUD, facilitating the transition from initial ideas to market-ready products. The program addresses the critical gap in early translational funding and aims to enhance the landscape of treatment options for substance use disorders by mentoring and educating researchers in formal product development. The maximum funding amount is $1.9 million per year, with applications accepted until November 13, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-056.html.
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Drug-Free Communities (DFC) Support Program - NEW (Year 1)
    Active
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is forecasting the availability of grants under the Drug-Free Communities (DFC) Support Program for Fiscal Year 2025. This program aims to establish and strengthen community coalitions focused on preventing youth substance use, with the overarching goals of fostering collaboration among various stakeholders and reducing substance abuse among youth and adults. Eligible applicants include nonprofit organizations with 501(c)(3) status, community-based coalitions, and other entities that support these initiatives, with a total estimated funding of $62.5 million and an award ceiling of $125,000 per grant. Interested parties should note that applications must be submitted electronically by March 25, 2025, and can direct inquiries to Brandis Belser at dfcnofo@cdc.gov.